CLL's 'Very Unusual Year'

Dr. Bruce Cheson discusses how to choose among the new, exciting options available for the treatment of chronic lymphocytic leukemia: obinutuzumab, ibrutinib, and idelalisib.

Source: Medscape Oncology - August 20, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts